Male infertility is a widespread disorder in which a man is unable to impregnate a fertile female.
Male infertility is a widespread disorder in which a man is unable to impregnate a fertile female. If in 12 months of unprotected intercourse the couple is unable to conceive, then infertility can be viewed as a cause. One of the major causes for male infertility is stress. High levels of oxidative stress can damage normal spermatozoa by inducing lipid peroxidation and DNA damage, and are associated with poor sperm production and subfertility. Moreover, prevalence of chronic diseases such as Azoospermia, testosterone deficiency, prostate cancer and other diseases, abnormal sperm function or blockages, illnesses, injuries, torpid lifestyle, consumption of alcohol or drugs, smoking, and obesity can also play a role in causing male infertility. These are major factors driving growth of the global male infertility market.
Male infertility factor is a primary cause for low birth rates in many countries across the globe. Males diagnosed with infertility tend to undergo high stress levels, embarrassment among other emotional changes, which further intensify the problem. Emotional shock and discontinuation of treatment is the key limitation which directly affects growth of the global male infertility market. In addition, high-cost of treatment is also another factor limiting market growth. However, opportunities expected to drive market growth in future include continuous R&D initiatives to develop more efficient cures, and introduction of low-cost treatments, rising medical tourism trend, rising disposable income, and increasing awareness among the male population regarding the potential benefits of treatments.
Region-wise, North America is dominating the global male infertility treatment market due to high literacy rate coupled with increasing number of healthcare centers. Europe is the second largest market for global male infertility treatment market, with growth mainly attributed to rising stress levels, obesity, and torpid lifestyle. The market in Asia Pacific is expected to witness highest CAGR during the analysis period owing to most of the above-mentioned factors along with increasing per capita income and spending capacity among consumers in the region.
To Obtain All-Inclusive Information On Forecast Analysis, Request A FREE Pdf Sample Report Here: https://marketresearch.biz/report/male-infertility-market/request-sample/
Key Players include ASKA Pharmaceutical, Halotech DNA, Merck Serono, and Zydus Cadila Healthcare. Other prominent players include AbbVie, Apricus Biosciences, Aytu BioScience, and others.